{"pmid":32295658,"title":"Shelter hospital: glimmers of hope in treating COVID-19.","text":["Shelter hospital: glimmers of hope in treating COVID-19.","Disaster Med Public Health Prep","Zhou, Feng","Gao, Xuan","Li, Mengwei","Zhang, Ying","32295658"],"journal":"Disaster Med Public Health Prep","authors":["Zhou, Feng","Gao, Xuan","Li, Mengwei","Zhang, Ying"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32295658","week":"202016|Apr 13 - Apr 19","doi":"10.1017/dmp.2020.105","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664266651138260992,"score":8.233237,"similar":[{"pmid":32237918,"title":"Chloroquine and hydroxychloroquine to treat COVID-19: between hope and caution.","text":["Chloroquine and hydroxychloroquine to treat COVID-19: between hope and caution.","Clin Toxicol (Phila)","Megarbane, Bruno","32237918"],"journal":"Clin Toxicol (Phila)","authors":["Megarbane, Bruno"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32237918","week":"202014|Mar 30 - Apr 05","doi":"10.1080/15563650.2020.1748194","source":"PubMed","topics":["Treatment"],"weight":1,"e_drugs":["Chloroquine","Hydroxychloroquine"],"_version_":1663352135556792320,"score":72.347},{"pmid":32247320,"title":"Fangcang shelter hospitals: a novel concept for responding to public health emergencies.","text":["Fangcang shelter hospitals: a novel concept for responding to public health emergencies.","Fangcang shelter hospitals are a novel public health concept. They were implemented for the first time in China in February, 2020, to tackle the coronavirus disease 2019 (COVID-19) outbreak. The Fangcang shelter hospitals in China were large-scale, temporary hospitals, rapidly built by converting existing public venues, such as stadiums and exhibition centres, into health-care facilities. They served to isolate patients with mild to moderate COVID-19 from their families and communities, while providing medical care, disease monitoring, food, shelter, and social activities. We document the development of Fangcang shelter hospitals during the COVID-19 outbreak in China and explain their three key characteristics (rapid construction, massive scale, and low cost) and five essential functions (isolation, triage, basic medical care, frequent monitoring and rapid referral, and essential living and social engagement). Fangcang shelter hospitals could be powerful components of national responses to the COVID-19 pandemic, as well as future epidemics and public health emergencies.","Lancet","Chen, Simiao","Zhang, Zongjiu","Yang, Juntao","Wang, Jian","Zhai, Xiaohui","Barnighausen, Till","Wang, Chen","32247320"],"abstract":["Fangcang shelter hospitals are a novel public health concept. They were implemented for the first time in China in February, 2020, to tackle the coronavirus disease 2019 (COVID-19) outbreak. The Fangcang shelter hospitals in China were large-scale, temporary hospitals, rapidly built by converting existing public venues, such as stadiums and exhibition centres, into health-care facilities. They served to isolate patients with mild to moderate COVID-19 from their families and communities, while providing medical care, disease monitoring, food, shelter, and social activities. We document the development of Fangcang shelter hospitals during the COVID-19 outbreak in China and explain their three key characteristics (rapid construction, massive scale, and low cost) and five essential functions (isolation, triage, basic medical care, frequent monitoring and rapid referral, and essential living and social engagement). Fangcang shelter hospitals could be powerful components of national responses to the COVID-19 pandemic, as well as future epidemics and public health emergencies."],"journal":"Lancet","authors":["Chen, Simiao","Zhang, Zongjiu","Yang, Juntao","Wang, Jian","Zhai, Xiaohui","Barnighausen, Till","Wang, Chen"],"date":"2020-04-06T11:00:00Z","year":2020,"_id":"32247320","week":"202015|Apr 06 - Apr 12","doi":"10.1016/S0140-6736(20)30744-3","source":"PubMed","locations":["Fangcang","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1663352136171257856,"score":55.15863},{"pmid":32239125,"title":"[Remdesivir, the antiviral hope against SARS-CoV-2].","text":["[Remdesivir, the antiviral hope against SARS-CoV-2].","On December 31, 2019 a pneumonia outbreak caused by a new coronavirus (SARS-CoV-2) was detected in the city of Wuhan (China). Due to the high capacity of diffusion and human infection it has become a new zoonotic pandemic. The absence of a vaccine has determined the search for antiviral drugs with the capacity to inhibit the replication of the new virus. Among them, remdesivir, an analogue of adenosine, is what seems to have a more promising future. This drug has shown in vitro and in animals a high capacity to block infection and viral replication with attainable concentrations in human plasma. Although all studies have been carried out with SARS-CoV and MERS-CoV, it seems that by virological and functional analogy, remdesivir is one of the few antiviral drugs with proven efficacy. However, studies and clinical trials in humans are required to know the result of their application in them.","Rev Esp Quimioter","Reina, J","32239125"],"abstract":["On December 31, 2019 a pneumonia outbreak caused by a new coronavirus (SARS-CoV-2) was detected in the city of Wuhan (China). Due to the high capacity of diffusion and human infection it has become a new zoonotic pandemic. The absence of a vaccine has determined the search for antiviral drugs with the capacity to inhibit the replication of the new virus. Among them, remdesivir, an analogue of adenosine, is what seems to have a more promising future. This drug has shown in vitro and in animals a high capacity to block infection and viral replication with attainable concentrations in human plasma. Although all studies have been carried out with SARS-CoV and MERS-CoV, it seems that by virological and functional analogy, remdesivir is one of the few antiviral drugs with proven efficacy. However, studies and clinical trials in humans are required to know the result of their application in them."],"journal":"Rev Esp Quimioter","authors":["Reina, J"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32239125","week":"202014|Mar 30 - Apr 05","doi":"10.37201/req/098.2020","keywords":["*SARS-CoV-2","*remdesivir","*treatment"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"e_drugs":["remdesivir","Adenosine"],"_version_":1663352135493877761,"score":53.347656},{"pmid":32223769,"title":"Shelter hospital mode: how to prevent novel coronavirus infection 2019 (COVID-19) hospital-acquired infection?","text":["Shelter hospital mode: how to prevent novel coronavirus infection 2019 (COVID-19) hospital-acquired infection?","Infect Control Hosp Epidemiol","Yang, Yong","Wang, Hailian","Chen, Kang","Zhou, Jun","Deng, Shaoping","Wang, Yi","32223769"],"journal":"Infect Control Hosp Epidemiol","authors":["Yang, Yong","Wang, Hailian","Chen, Kang","Zhou, Jun","Deng, Shaoping","Wang, Yi"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32223769","week":"202014|Mar 30 - Apr 05","doi":"10.1017/ice.2020.97","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663352135229636608,"score":52.9201},{"pmid":32172487,"title":"Back to the spring of Wuhan: facts and hope of COVID-19 outbreak.","text":["Back to the spring of Wuhan: facts and hope of COVID-19 outbreak.","Front Med","Zhou, Guangbiao","Chen, Saijuan","Chen, Zhu","32172487"],"journal":"Front Med","authors":["Zhou, Guangbiao","Chen, Saijuan","Chen, Zhu"],"date":"2020-03-16T11:00:00Z","year":2020,"_id":"32172487","week":"202012|Mar 16 - Mar 22","doi":"10.1007/s11684-020-0758-9","source":"PubMed","locations":["Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1663352133930450944,"score":49.24963}]}